MEDIA

All Media

___LZSettings_N4IghgdglgtmAuUD2EDOIBcBtAugGnAFd4kBhAJyQAdN5zCBTAgI3IbAGsqkoJ4B5AG4Ny5KABMG6DMAC+BAMZIANsoYLEKAJLjMIAGwBOBQCZmC-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-gApRDJZUFi6-IkFQlV6MGkoEoTQJDRAiJvglejEwWQz0CDIEkLVkw1QCleKNAJ4ZBAB8YhROwMhfQg3z0ABSEBhn6YDQKfDAIKgmCiXg78CGoMAFH7JDQBQ8DIIIaD+zghDcMqSp3iDQD70fFEMMookqCeRCmLA59yMwkAOIQ4ZenyXgbyA4jmKmVj32wggiJAqSMEmGSqJwz0OANcTuNQ1SiU-aiQAUkjeNfNiP26IThhBU01BrMBESQq13gIV5lBTOlpGcj5+wYM8tAgCdySnGdbOlNkYjiaQZhAJozWlABxMZ6lRF8YCQZgagYCLYjQSJ0QyrKkvgcZTLJJ152UaMIxaS1Xhcz4kCdGr4SRFFrAIclDyoLQ6jPRIUjrCAGzq60816TdYnFEJer89M3UpVAJo2fNyThZIwDYAAhMYUHmpB1s2j1mF2tAtBped8kXOk9H9WkJhYU7UHOlAtz0VA4FUDYTpKvaXogCLej0M18IbR7frOmk4XgEJByJVAAEdCCOykHnIBYNidVkECCZpSGUSN3n2iAPSUVR1AJGNyGUPQAHoSfJVBKUgcRKSoNhUCZupvjZ7YNkId4ADl2xEAKgqHWKws3aVECTaRuQ+dLMrUOEZd4PJ5dLEA2FeLayW1HRgf1jhKRCTUAH1XHNuwAHZzZMa3rZtgAOZ3XH0Ox9EyT3JnN6xnZthCgA
FGA Trust Commits $7 Million to Accelerate Research For Diffuse Midline Glioma
FGA Trust Commits $7 Million to Accelerate Research For Diffuse Midline Glioma

FGA Trust commits $7 million to accelerate research for diffuse midline glioma

Read more →
PNOC Foundation Welcomes Pediatric Cancer Advocate Rob Stuart to Its Board of Directors
PNOC Foundation Welcomes Pediatric Cancer Advocate Rob Stuart to Its Board of Directors

Rob Stuart brings community-rooted fundraising experience to PNOC Foundation's board

Read more →
First Patient Enrolled in PNOC035 Clinical Trial for Recurrent ATRT
First Patient Enrolled in PNOC035 Clinical Trial for Recurrent ATRT

PNOC Foundation celebrates the launch of PNOC035, a groundbreaking clinical trial for children, adolescents, and young adults with recurrent or progressive atypical teratoid rhabdoid tumor (ATRT).

Read more →
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough

The New York Times: For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough, July 16, 2026

Read more →
PNOC Foundation Appoints Biopharma Executive Jeremy Bender to Its Board of Directors
PNOC Foundation Appoints Biopharma Executive Jeremy Bender to Its Board of Directors

Biopharma leader and longtime PNOC collaborator Jeremy Bender, brings firsthand experience turning pediatric brain cancer research into approved treatments.

Read more →
PNOC Foundation Invites United MileagePlus Members to Donate Miles to Help Pediatric Brain Cancer Research
PNOC Foundation Invites United MileagePlus Members to Donate Miles to Help Pediatric Brain Cancer Research

Your United Airlines miles could help the world’s leading pediatric brain tumor experts collaborate on lifesaving treatments for the deadliest childhood cancers.

Read more →
The Max Pound Foundation deepens PNOC support with additional $50,000 gift
The Max Pound Foundation deepens PNOC support with additional $50,000 gift

The Pediatric Neuro-Oncology Consortium (PNOC) is honored to announce an additional $50,000 gift from the Max Pound Foundation, continuing and expanding the foundation’s longstanding commitment to accelerating progress for children with brain cancer.

Read more →
PNOC Foundation launches $50 million “Lose No Child” Campaign
PNOC Foundation launches $50 million “Lose No Child” Campaign

PNOC Foundation announces the launch of their Lose No Child: a $50 million campaign to accelerate progress against pediatric brain cancer.

Read more →
ONC201 FDA drug approval for Diffuse Midline Glioma
ONC201 FDA drug approval for Diffuse Midline Glioma

FDA grants accelerated approval to dordaviprone (Modeyso, Jazz Pharmaceuticals, Inc.), a protease activator, for adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy.

Read more →
Measles Oncolytic Virus as an Immunotherapy
Measles Oncolytic Virus as an Immunotherapy

Clinical Cancer Research Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005, August, 2025

Read more →
PNOC Foundation Enhances Donation Options
PNOC Foundation Enhances Donation Options

PNOC Foundation Enhances Donation Options to Accelerate Pediatric Brain Cancer Research

Read more →
Measles Oncolytic Virus as an Immunotherapy (Copy)
Measles Oncolytic Virus as an Immunotherapy (Copy)

Pediatric Neuro-Oncology Consortium Partnership Receives Prestigious ARPA-H Multi-Million Dollar Grant for Groundbreaking RADIANT Project, to Rapidly Advance Treatments for Children With Brain Tumors

Read more →
Tovorafenib FDA Approval for low-grade glioma
Tovorafenib FDA Approval for low-grade glioma

PNOC Foundation announces FDA approval of tovorafenib (day101) in partnership with pnoc scientific consortium and day one biopharmaceuticals

Read more →
Neuro-Oncology Rational combination platform trial design
Neuro-Oncology Rational combination platform trial design

Rational combination platform trial design for children and young adults with diffuse midline glioma

Read more →

Press Releases

___LZSettings_N4IghgdglgtmAuUD2EDOIBcBtAugGnAFd4kBhAJyQAdN5zCBTAgI3IbAGsqkoJ4B5AG4Ny5KABMG6DMAC+BAMZIANsoYLEKAJLjMIAGwBOBQCZmC-SZMAWawEZ7dkwyMBma+LDWQilWo3IEAAqAJ5UDJh2vsqEMBAA6hLwABaYJvoADASSqFAA5hB6YMRIeWK6BABmUMrwIpig8GB5mBCEqooIDHlI5CF6AApsqKgABABKDGpgqFIg8iB5xHXkmACsJgTJ7JLkQQwAHvB6PiCwzQwAgqjhGuMIyHp2AHRrp8r5yfDMSAeYlWBlLMCB9UPAtHA8lcPgUYAw+Ho1JVjiCoGCIRcAMpQABeEQwNgIcKaniaAyQuU0hQwIGYUyQAHcALRKPjwlEgGBQA4McSkFB1BEYOiMAhULG4-HWfRisRwPoAWQYJIQYD0pIisqQ4kIGgAioQoAoOAA1KAMBkAUQgYGYal0GABQKYIFmrM8iuVYFJappEBQmtdyUZloOChEVGOwvoLtQwYZAxmAnIAFUqEouRA8pbhHxpCBCOmkJmWgQ44yhkb8SLY-HJt6Fb0GAAZXgcWgxsvxoLJWLMG01DuioOMoJQeBqIexj45AYicaMzCuAh1I6XGEQOFCkBIjmr+DYvF6OHiKCxU50SCoSq9GDSUCUJpUhogHEvwSAxiYLIF6BRkCSC0sgLKgCiAvioB-DIIAfjE+J2BkP6EH+egAKTzAQ-TQbBX4YAhSEoTS6HAQQ1BgAo45YaAOHwYhBDIeOaEYSASCVJUsxRpB76fviBGMTSVB-AsVEwTx370YRICCfMCy9PkvAvlB1FiRgax8f+xGYdxcHrOpTEka6HAWop2m4XpNKAcxIk0eJv78QB3QyQs8K2mozZgDiWFOsC4CqDm7LSN5Lrjgwd5aBAC4MkuK6ucq-IxHE0ibCATR2sqADiyz1ASP4wEgzA1Aw8WxGgkREvlhWZfAKy2coSDeuuyj8OQiYtI6gI+XV3qtQwh5SgQDLkGAVBaHUd6JCkrYQO27XOmWvQHrE8ohKNoX5v6TKoAtpzlgymLJGAbAAELLCg61IPth2Bswp1oForLrvkm7sno4ZsqsLC3ag90oH1eioHAqinDd1VnT9EDxb0eh2uR7afaDd2spi8AhJONKoAAjoQV1Mj85C7Kc3p8ggQTNKQygzLM50QIGSiqOoVIpuQyh6AA9DTDKoEykDiEyVDDFzdRgnzFynIQswAHJ9iI4WRVOMVpQeyqIFm0g1uVBVqJiyu8HkaudgWszayMgSkOR2zyyAbCAkddXGjo0N2xwuP2PoDjiAAHK4biGCYYAAOyVMwdLzEAA
FGA Trust Commits $7 Million to Accelerate Research For Diffuse Midline Glioma
FGA Trust Commits $7 Million to Accelerate Research For Diffuse Midline Glioma

FGA Trust commits $7 million to accelerate research for diffuse midline glioma

Read more →
PNOC Foundation Welcomes Pediatric Cancer Advocate Rob Stuart to Its Board of Directors
PNOC Foundation Welcomes Pediatric Cancer Advocate Rob Stuart to Its Board of Directors

Rob Stuart brings community-rooted fundraising experience to PNOC Foundation's board

Read more →
First Patient Enrolled in PNOC035 Clinical Trial for Recurrent ATRT
First Patient Enrolled in PNOC035 Clinical Trial for Recurrent ATRT

PNOC Foundation celebrates the launch of PNOC035, a groundbreaking clinical trial for children, adolescents, and young adults with recurrent or progressive atypical teratoid rhabdoid tumor (ATRT).

Read more →
PNOC Foundation Appoints Biopharma Executive Jeremy Bender to Its Board of Directors
PNOC Foundation Appoints Biopharma Executive Jeremy Bender to Its Board of Directors

Biopharma leader and longtime PNOC collaborator Jeremy Bender, brings firsthand experience turning pediatric brain cancer research into approved treatments.

Read more →
PNOC Foundation Invites United MileagePlus Members to Donate Miles to Help Pediatric Brain Cancer Research
PNOC Foundation Invites United MileagePlus Members to Donate Miles to Help Pediatric Brain Cancer Research

Your United Airlines miles could help the world’s leading pediatric brain tumor experts collaborate on lifesaving treatments for the deadliest childhood cancers.

Read more →
The Max Pound Foundation deepens PNOC support with additional $50,000 gift
The Max Pound Foundation deepens PNOC support with additional $50,000 gift

The Pediatric Neuro-Oncology Consortium (PNOC) is honored to announce an additional $50,000 gift from the Max Pound Foundation, continuing and expanding the foundation’s longstanding commitment to accelerating progress for children with brain cancer.

Read more →
PNOC Foundation Enhances Donation Options
PNOC Foundation Enhances Donation Options

PNOC Foundation Enhances Donation Options to Accelerate Pediatric Brain Cancer Research

Read more →
Measles Oncolytic Virus as an Immunotherapy (Copy)
Measles Oncolytic Virus as an Immunotherapy (Copy)

Pediatric Neuro-Oncology Consortium Partnership Receives Prestigious ARPA-H Multi-Million Dollar Grant for Groundbreaking RADIANT Project, to Rapidly Advance Treatments for Children With Brain Tumors

Read more →
Tovorafenib FDA Approval for low-grade glioma
Tovorafenib FDA Approval for low-grade glioma

PNOC Foundation announces FDA approval of tovorafenib (day101) in partnership with pnoc scientific consortium and day one biopharmaceuticals

Read more →
Neuro-Oncology Rational combination platform trial design
Neuro-Oncology Rational combination platform trial design

Rational combination platform trial design for children and young adults with diffuse midline glioma

Read more →

PNOC In the News

___LZSettings_N4IghgdglgtmAuUD2EDOIBcBtAugGnAFd4kBhAJyQAdN5zCBTAgI3IbAGsqkoJ4B5AG4Ny5KABMG6DMAC+BAMZIANsoYLEKAJLjMIAGwBOBQCZmC-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-A5SS+UKoLET+RIKhKr0YNJQJQmvSGiBCZ-BKDGJgslLaB4xASQWlkZZUAUUESVAIEZBAX8YhJOwMkAwhgL0ABSEBln6BCkP-DBUPQzDGRwiCCGoMAFBnfDQEIlC0IIDCZ2w3CqMqSpwXjOCfz-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
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough

The New York Times: For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough, July 16, 2026

Read more →

Scientific Publications

___LZSettings_N4IghgdglgtmAuUD2EDOIBcBtAugGnAFd4kBhAJyQAdN5zCBTAgI3IbAGsqkoJ4B5AG4Ny5KABMG6DMAC+BAMZIANsoYLEKAJLjMIAGwBOBQCZmC-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-A5SS+UKoLET+RIKhKr0YNJQJQmvSGiBCZ-BKDGJgslLaB4xASQWlkZZUAUUESVAIEZBAX8YhJOwMkAwhgL0ABSEBln6BCkP-DBUPQzDGRwiCCGoMAFBnfDQEIlC0IIDCZ2w3CqMqSpwXjOCfz-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-QwE9zZXEqVwGGsbYTAyXCgA
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough
For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough

The New York Times: For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough, July 16, 2026

Read more →